Orexin deficiency modulates the dipsogenic effects of angiotensin II in a sex-dependent manner.

Angiotensin II Drinking Hypocretin Orexin Polydipsia Sex differences

Journal

Peptides
ISSN: 1873-5169
Titre abrégé: Peptides
Pays: United States
ID NLM: 8008690

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 12 08 2023
revised: 10 11 2023
accepted: 28 11 2023
pubmed: 4 12 2023
medline: 4 12 2023
entrez: 3 12 2023
Statut: aheadofprint

Résumé

The orexin (hypocretin) neuropeptide system is an important regulator of ingestive behaviors, i.e., it promotes food and water intake. Here, we investigated the role of orexin in drinking induced by the potent dipsogen angiotensin II (ANG II). Specifically, male and female orexin-deficient mice received intracerebroventricular (ICV) injections of ANG II, followed by measuring their water intake within 15 min. We found that lower doses of ANG II (100 ng) significantly stimulated drinking in males but not in females, indicating a general sex-dependent effect that was not affected by orexin deficiency. However, higher doses of ANG II (500 ng) were sufficient to induce drinking in female wild-type mice, while female orexin-deficient mice still did not respond to the dipsogenic properties of ANG II. In conclusion, these results suggest sex-dependent effects in ANG II-induced drinking and further support the sexual dimorphism of orexin system functions.

Identifiants

pubmed: 38043589
pii: S0196-9781(23)00192-4
doi: 10.1016/j.peptides.2023.171127
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171127

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Nadine Faesel (N)

Institute for Pharmacology and Toxicology, Otto von Guericke University Magdeburg, Leipziger Straße 44, D-39120 Magdeburg, Germany; Department of Neuropharmacology, Brain Research Institute, University of Bremen, Hochschulring 18, D-28359 Bremen, Germany. Electronic address: nfaesel@uni-bremen.de.

Michael Koch (M)

Department of Neuropharmacology, Brain Research Institute, University of Bremen, Hochschulring 18, D-28359 Bremen, Germany. Electronic address: michael.koch@uni-bremen.de.

Markus Fendt (M)

Institute for Pharmacology and Toxicology, Otto von Guericke University Magdeburg, Leipziger Straße 44, D-39120 Magdeburg, Germany; Center for Behavioral Brain Sciences, Otto von Guericke University Magdeburg, Leipziger Straße 44, D-39120 Magdeburg, Germany. Electronic address: markus.fendt@med.ovgu.de.

Classifications MeSH